
| ID | 31826 |
| JaLCDOI | |
| フルテキストURL | |
| 著者 |
Fujikawa, Tatsuya
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Shiraha, Hidenori
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
|
| 抄録 | Serum des-gamma-carboxy prothrombin (DCP) is commonly used to detect hepatocellular carcinoma (HCC). This review focuses on the clinical features of DCP-positive HCC and the molecular function of DCP in HCC. DCP-positive HCC demonstrates more aggressive clinicopathological features than DCP-negative HCC. Analysis of the biological effects of DCP revealed that DCP acts as a growth factor in both an autocrine and paracrine manner. DCP stimulates HCC cell proliferation through the Met-Janus kinase 1-signal transducer and activator of transcription 3 signaling pathway, whereas for vascular endothelial cells, it stimulates cell proliferation and migration through the kinase insert domain receptor-phospholipase C-gamma-mitogen-activated protein kinase signaling pathway. |
| キーワード | des-gamma-carboxy prothrombin
hepatocellular carcinoma
signaling pathway
cell proliferation
angiogenesis
|
| Amo Type | Review
|
| 出版物タイトル |
Acta Medica Okayama
|
| 発行日 | 2009-12
|
| 巻 | 63巻
|
| 号 | 6号
|
| 出版者 | Okayama University Medical School
|
| 開始ページ | 299
|
| 終了ページ | 304
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| 論文のバージョン | publisher
|
| 査読 |
有り
|
| PubMed ID | |
| Web of Science KeyUT |